• 1.1 – Antithrombotic therapy – Percentage of hospitalised adult patients that are assessed for risk of venous thromboembolism (PDF and Word)
  • 1.2 – Antithrombotic therapy – Percentage of hospitalised adult patients that receive venous thromboembolism prophylaxis appropriate to their level of risk (PDF and Word)
  • 1.3 – Antithrombotic therapy – Percentage of patients prescribed enoxaparin whose dosing schedule is appropriate (PDF and Word)
  • 1.4 – Antithrombotic therapy – Percentage of patients prescribed hospital initiated warfarin whose loading doses are consistent with a drug and therapeutics committee (PDF and Word)
  • 1.5 – Antithrombotic therapy – Percentage of patients with an INR above 4 whose dosage has been adjusted or reviewed prior to the next warfarin dose (PDF and Word)
  • 1.6 – Antithrombotic therapy – Percentage of patients with atrial fibrillation that are discharged on oral anticoagulants (PDF and Word)
  • 2.1 – Antibiotic therapy – Percentage of patients undergoing specified surgical procedures that receive an appropriate prophylactic antibiotic regimen (PDF and Word)
  • 2.2 – Antibiotic therapy – Percentage of prescriptions for restricted antibiotics that are concordant with drug and therapeutics committee approved criteria (PDF and Word)
  • 2.3 – Antibiotic therapy – Percentage of patients prescribed hospital initiated warfarin whose (PDF and Word)
  • 2.4 – Antibiotic therapy – Percentage of adult patients with community acquired pneumonia (PDF and Word)
  • 2.5 – Antibiotic therapy – Percentage of patients presenting with community acquired pneumonia (PDF and Word)
  • 3.1 – Medication ordering – Percentage of patients whose current medicines are documented and reconciled at admission (PDF and Word)
  • 3.2 – Medication ordering – Percentage of patients whose known adverse drug reactions are documented on the current medication chart (PDF and Word)
  • 3.3 – Medication ordering – Percentage of medication orders that include error-prone abbreviations (PDF and Word)
  • 3.4 – Medication ordering – Percentage of paediatric medication orders that include the correct dose per kilogram (or body surface area) AND an effective and safe total dose (PDF and Word)
  • 3.5 – Medication ordering – Percentage of medication orders for intermittent therapy that are prescribed safely (PDF and Word)
  • 3.6 – Medication ordering – Percentage of patients receiving cytotoxic chemotherapy whose treatment is guided by a hospital approved chemotherapy treatment protocol (PDF and Word)
  • 4.1 – Pain management – Percentage of postoperative patients whose pain intensity is documented using an appropriate validated assessment tool (PDF and Word)
  • 4.2 – Pain management – Percentage of postoperative patients that are given a written pain management plan at discharge AND a copy is communicated to the primary care clinician (PDF and Word)
  • 5.1 – Continuity of care – Percentage of patients with acute coronary syndrome that are prescribed appropriate medicines at discharge (PDF and Word)
  • 5.2 – Continuity of care – Percentage of patients with systolic heart failure that are prescribed appropriate medicines at discharge (PDF and Word)
  • 5.3 – Continuity of care – Percentage of discharge summaries that include medication therapy changes and explanations for changes (PDF and Word)
  • 5.4 – Continuity of care – Percentage of patients on warfarin that receive written information regarding warfarin management prior to discharge (PDF and Word)
  • 5.5 – Continuity of care – Percentage of patients with a new adverse drug reaction (ADR) that are given written ADR information at discharge AND a copy is communicated to the primary care clinician (PDF and Word)
  • 5.6 – Continuity of care – Percentage of patients with asthma that are given a written asthma action plan at discharge AND a copy is communicated to the primary care clinician (PDF and Word)
  • 5.7 – Continuity of care – Percentage of patients receiving sedatives at discharge that were not taking them at admission (PDF and Word)
  • 5.8 – Continuity of care – Percentage of patients whose discharge summaries contain a current, accurate and comprehensive list of medicines (PDF and Word)
  • 5.9 – Continuity of care – Percentage of patients who receive a current, accurate and comprehensive medication list at the time of hospital discharge (PDF and Word)
  • 6.1 – Hospital-wide medication management policies – Percentage of medication storage areas outside pharmacy where potassium ampoules are available (PDF and Word)
  • 6.2 – Hospital-wide medication management policies – Percentage of patients that are reviewed by a clinical pharmacist within one day of admission (PDF and Word)
  • 6.3 – Hospital-wide medication management policies – Percentage of parenteral opioid dosage units that are pethidine (PDF and Word)
  • 6.4 – Hospital-wide medication management policies – Percentage of submissions for formulary listing of new chemical entities for which the drug and therapeutics committee has access to adequate information for appropriate decision making (PDF and Word)
  • 7.1 – Acute mental health care – Percentage of as required (PRN) psychotropic medication orders with documented indication, dose (or dose range), frequency and maximum daily dose specified (PDF and Word)
  • 7.2 – Acute mental health care – Percentage of patients taking lithium who receive appropriate monitoring during their inpatient episode (PDF and Word)
  • 7.3 – Acute mental health care – Percentage of patients who receive written and verbal information on regular psychotropic medicines initiated during their admission (PDF and Word)
  • 7.4 – Acute mental health care – Percentage of patients taking antipsychotic medicines who receive appropriate monitoring for the development of metabolic side effects (PDF and Word)
  • 7.5 – Acute mental health care – Percentage of patients prescribed two or more regular antipsychotic medicines at hospital discharge (PDF and Word)